Dr. Loma Parikh

Professional Bio:

• Dr. Loma Parikh is currently working as a Consultant Surgical Pathology & Cytopathology at Zydus Cancer Hospital & Zydus Hospitals, Ahmedabad. Her areas of interest are Surgical Oncopathology with Immunohistochemistry and molecular studies, Medical Liver Biopsy & Endoscopic Gastrointestinal Biopsies, - Peritoneal Malignancies, Quality control in pathology, Development of newer tests in the laboratory, Digital Pathology & Developing Artificial Intelligence in Pathology, Newer Technology with Total automation in laboratory and Leadership & Strategy Building for Business Expansion.

Academic Details:

• MBBS (2007): Smt NHL Municipal Medical College, Ahmedabad
• MD Pathology (2011): Gujarat Cancer & Research Institute (GCRI), Ahmedabad
• SR- Oncopathology (2012): TATA Memorial Hospital, Mumbai
• Fellowship-Gastrointestinal & Hepatobiliary (2013): KEM Hospital, Mumbai

Past associations:

• EX-SR - Tata Memorial Hospital, Mumbai (Oncopathology)
• Fellow - Gastro & Hepatobiliary Pathology, KEM Hospital, Mumbai.
• Previously, she has worked as a consultant at HCG Cancer Hospital, Ahmedabad & Sanket Metropolis Healthcare, Ahmedabad. She did Senior Residency at Prestigious cancer institute of India at Tata Memorial Hospital, Mumbai. She did Fellowship in Gastrointestinal & Hepatobiliary pathology from KEM Hospital, Mumbai.

Expertise and Specialties:

• Surgical pathology (Range of Non-neoplastic & Neoplastic specimens) with special interest towards Gynec Onco-pathology and Gastrointestinal Biopsies & Medical Liver Biopsies.
• >1000 Frozen sections (Of various systems including rare variety) handling and reporting.
• Cytopathology including Body fluids, Pap smears, FNAC.
• Reported more than 130 Peritoneal malignancies -including Pseudomyxoma Peritonei (PMP).
• Expertise in Endoscopic Gastrointestinal Biopsies & Medical Liver Biopsies.
• Expertise in Developing a new test (Including Immunohistochemistry).
• Hematopathology.
• Bone marrow examination of various non neoplastic conditions.
• Expansion of Test Scope, Maintain Quality Standards, Team Building & Cost Optimization.
• To utilize all academic as well as professional knowledge & experience towards the organizational objectives.

Papers:

• Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-Center Study. Ann Surg Oncol.
• 2020 Nov 18 Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide. Indian J Surg Oncol.
• 2020 Mar Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide. Indian J Surg Oncol.
• 2020 March Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric study. Eur J Surg Oncol.
• 2019 Dec Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index.
• Colorectal Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications. Eur J Surg Oncol.
• 2021 Jan The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs from the Surgical PCI in Peritoneal Metastases Arising from Various Primary Tumors. Ann Surg Oncol.
• 2020 Aug Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications. Eur J Surg Oncol.
• 2020 Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease? Eur J Surg Oncol.
• 2020 Apr Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer
• A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO). Eur J Surg Oncol.
• 2019 Lacrimal Gland Adenoid Cystic Carcinoma with High Grade Transformation: A Case Report and Current Concepts in Multi- Modality Management.
• Indian Journal of Otolaryngology and Head & Neck Surgery (2020) CO-AUTHOR IN BOOK
• Glehen, Olivier & Bhatt, Aditi. (2020). Pathology of Peritoneal Metastases: The Unchartered Fields.